Adverse Drug Reactions during the Administration of General Anesthetic Drugs – Drug Therapy Example

Download free paperFile format: .doc, available for editing

"Adverse Drug Reactions during the Administration of General Anesthetic Drugs" is a perfect example of a paper on drug therapy.   Adverse drug reaction is described by the Union of Anesthetists of Ireland and Britain as any medication reaction that is not curative, diagnostic, and prophylactic to the patient. Adverse drug reactions are significant complexities of modern drug therapies, and its awareness has remarkably increased. Anesthetists are currently faced with a plethora of drug adverse reaction cases. ADR usually takes place during the introduction of anesthesia, though it may take place at any time during the perioperative stage.

The most regularly recorded ADR manifestation during general anesthesia is cardiovascular fail, a comparatively late event. The initial indications usually are masked during anesthesia (Naguib, Magboul, & Jaroudi, 1998). Allergic Reactions to Anesthesia It now appears possible that most severe ADRs taking place during induction of anesthesia are naturally immunological. For reasons not known, allergic reactions seem to be expected in young adults and women. Patients with a severe atopic history and higher serum immunoglobulin are at a greater risk of adverse drug reactions. Nonetheless, about 50% of all the reactions take place in non-atopic patients who do not have a hypertension history to other medications.

Therefore, a past of atopy is of small anticipative value, though atopic people might be predisposed to adverse or life-threatening ADRs should anaphylaxis takes place. Prior medication exposure is a feature in individual patients, though a history of previous uneventful experiences with a drug does not eradicate the probability of adverse allergic reactions on consequent exposure (Naguib, Magboul, & Jaroudi, 1998). Respiratory Depression This is regarded as the most remarkable side effect of all medications used for practical sedation as well as general anesthesia.

Nonetheless, it is critical to differentiate respiratory depression from anatomical obstruction of the airway. Most drugs used in procedural sedation and anesthesia generate glossopharyngeal musculature relaxation and hence decrease pharyngeal patency. Even mild extents of respiratory depressions might be powerful to stop patients from overpowering the obstructions, though patients will, in general, breathe if the airway patency is enhanced.   Usually, it is always good practice to place the patient upright, slant the head upward and obtrude the mandibles when needed.

The respiratory depression goes on in a dose-reaction way, and the degree is further escalated when different classes are used together. Minimal to regulate sedation has a small risk for clinically remarkable respiratory depression, though intense anesthesia initiates significant risk for both airway obstruction and respiratory depression. For instance, the opioids basically depress the central hypercapnic drive while the powerful agents of inhalation depress the hypoxemic drive. At increased doses, there is selectivity, and both drives are depressed (Becker, 2014). Metabolic and Endocrine Effects   Barbiturates may precipitate acute and even fatal hits of porphyria because of the introduction of aminolevulinic acid synthetase that catalyzes the rate restricting phase in the porphyrins biosynthesis.

In severe intermittent porphyria, barbiturates can precipitate cranial nerves as well as peripheral demyelination and disseminate lesions all through the CNS, hence leading to colicky pain, vomiting, and nausea, adverse constipation, weakness, and paralysis. Ketamine seems to be porphyrinogenic at greater concentrates, though not utilized clinically. Profil has been utilized devoid of provoking porphyria in vulnerable individuals. Medications that are regarded as appropriate for individuals with porphyria incorporates atropine, neostigmine, suxamethonium, vecuronium bromide, among others.

Adrenal suppression, which is not responsive, can be seen after an introduction of etomidate as anesthesia. Nevertheless, adrenal suppression usually is temporary, and the adrenal functions get back to normal in a period of 24 hours. Therefore, the remarkable adrenal suspension will occur when etomidate is provided for a longer period. Adrenal suppression is of no clinical significance when etomidate is given as a single dose (Naguib, Magboul, & Jaroudi, 1998). Drug Interactions during the Administration of General Anesthetic Drugs                       Anesthetic drug interaction is present when one anesthetic affects the performance of the other anesthetic.

The combined impact may be improved or weakened, or even a new impact may take place. The new impacts may be curative or unexpected side effects. During anesthesia, physicians make curative decisions regularly incorporating numerous medications. Anesthesiologists are faced with anesthetic medications and medication interaction daily. Anesthetic impacts are attained by the use of either drug combination or a single drug. All medications, in combination, contribute to the general impact; most combinations reduce the dose of every individual anesthetic when contrasted to doses of individual medications needed to attain an equivalent impact.

Using interaction can reduce the adversity or happenings of severe impacts without hindering desired outcomes (Hannivoort et al. , 2016). In spite of many years of training, physicians might not be grateful for the importance of drug interactions and might give excess anesthetic doses, hindering recovery, or heightening the risk for severe effects. Research has defined many anesthetic interactions and novel display techniques have been created to visualize these interactions at the patient’ s bedside. These current technologies can give a more proof-based method of administration of anesthetic medication.

Anesthetic medications are known to affect the pharmacokinetic profile of each other by changing distribution clearance or volumes. Even though numerous studies have illustrated the significance of such interactions, the key objective in anesthesia practice is to control effects instead of concentration. Pharmacokinetic interactions, in the long run, lead to pharmacodynamic alterations (Hannivoort et al. , 2016).                       One key problem caused by the induction of efficient medication is an augmented possibility of a drug interaction. Even though some of these interactions are important, most are both harmful and unanticipated and may threaten the patient’ s safety.

Anesthetists need a management scheme that enables them to anesthetize individuals on therapy with any of the broad variety of medications available. As a help to comprehending, they require classification or scheme of probable interaction and information on various medication interactions, both when struggling to memorize facts and when faced with emergencies. The principles governing drug interactions include obtaining enough history of present and past drug treatment and of any unanticipated repercussion. The anesthetist should be in the know of the impacts and dangers that such medication treatment may bring about in combination with surgery and anesthesia.

The doctor should take enough safety measures for resuscitating the patient. They should use anesthetic methods that are familiar and usual. They should remember the drug interactions that have effects on the normal methods and the agent’ s selection. Finally, the anesthetist should give only enough of any drug to give the expected effect (Grogono 1974). The three types of drug interactions include additives, synergistic, and infra-additives, when the combined impact of the medications is higher, equal, or less than the summation of the impacts of either single medication, correspondingly.

Synergistic drug interactions are useful since they permit lower doses of every drug to be utilized. And hence have the likelihood of reducing the side effects (Diz et al. , 2010).


Becker, D. E. (2014). Adverse drug reactions in dental practice. Anesthesia Progress, 61(1), 26-34.

Diz, J. C., Del Río, R., Lamas, A., Mendoza, M., Durán, M., & Ferreira, L. M. (2010). Analysis of pharmacodynamic interaction of sevoflurane and propofol on Bispectral Index during general anaesthesia using a response surface model. British journal of anaesthesia, 104(6), 733-739.

Grogono, A. W. (1974). Drug interactions in anaesthesia. British Journal of Anaesthesia, 46(8), 613-618.

Hannivoort, L. N., Vereecke, H. E., Proost, J. H., Heyse, B. E., Eleveld, D. J., Bouillon, T. W., ... & Luginbühl, M. (2016). Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil. BJA: British Journal of Anaesthesia, 116(5), 624-631.

Naguib, M., Magboul, M. M., & Jaroudi, R. (1998). Adverse effects of general anaesthetics. CNS drugs, 10(2), 119-144.

Download free paperFile format: .doc, available for editing
Contact Us